Showing results (2151-2160 of 2,190) with videos related to

Sort By:
Pageof 219
Annals of Neurology|September 12, 2024
Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)Widad Abou Chaar, Anirudh N Eranki, Hannah A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Science (New York, N.Y.)|March 9, 2013
Evidence for a common mechanism of SIRT1 regulation by allosteric activatorsBasil P Hubbard, Ana P Gomes, Han Dai, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
The Lancet. Diabetes & Endocrinology|January 28, 2017
Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveysPeter Ueda, Mark Woodward, Yuan Lu, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Journal of Hematology & Oncology|April 14, 2021
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myelomaMaria V Mateos, Maria Gavriatopoulou, Thierry Facon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Journal of Medicinal Chemistry|February 21, 2023
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite LossMichelle R Garnsey, Aaron C Smith, Jana Polivkova, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled ReceptorEthan L Fisher, Anne-Marie Dechert Schmitt, Jamison B Tuttle, et al.
Pageof 219